Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 4Prostatic Neoplasms 2Venous Thromboembolism 1Thrombocythemia, Essential 1Smoking Cessation 1Primary Myelofibrosis 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Leukemia, Hairy Cell 1Inflammation 1Hemorrhage 1Fibrosis 1Fallopian Tube Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Carcinoma 1Breast Neoplasms 1Barrett Esophagus 1Adenocarcinoma Of Esophagus 1

Interventions

Fulvestrant 63Letrozole 53Paclitaxel 49Trastuzumab 41pembrolizumab 40ribociclib 37Specimen Handling 37palbociclib 36Capecitabine 34Carboplatin 33Anastrozole 33Tamoxifen 32exemestane 29pertuzumab 28abemaciclib 28Magnetic Resonance Spectroscopy 26Cyclophosphamide 26trastuzumab deruxtecan 24Surveys and Questionnaires 21Radiotherapy 18Biopsy 18olaparib 17Standard of Care 16Docetaxel 16Blood Specimen Collection 16Taxes 14Mastectomy, Segmental 14eribulin 13elacestrant 13130-nm albumin-bound paclitaxel 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Aspirin × 90 days × Clear all
NCT05557877 2026-05-12

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Mayo Clinic

Phase 2 Recruiting
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡